AMENDMENT 1 TO LICENSE AGREEMENTLicense Agreement • September 21st, 2015 • Mesoblast LTD • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledSeptember 21st, 2015 Company Industry JurisdictionThis Amendment (“Amendment”) to the License Agreement is made and entered into as of the date of the last signature on the signature page below (the “Effective Date of Amendment”), by and between JCR Pharmaceuticals Co. Ltd., a Japanese corporation (“JCR”), and Osiris Acquisition II, Inc., doing business as Osiris Therapeutics, Inc., a Delaware corporation (“OSIRIS”), with reference to the following background:
AMENDMENT 1 TO LICENSE AGREEMENTLicense Agreement • December 10th, 2014 • Mesoblast LTD • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledDecember 10th, 2014 Company Industry JurisdictionThis Amendment (“Amendment”) to the License Agreement is made and entered into as of the date of the last signature on the signature page below (the “Effective Date of Amendment”), by and between JCR Pharmaceuticals Co. Ltd., a Japanese corporation (“JCR”), and Osiris Acquisition II, Inc., doing business as Osiris Therapeutics, Inc., a Delaware corporation (“OSIRIS”), with reference to the following background: